Expand QNRX Menu
QNRX MENU

QNRX Latest Press Releases

-- March 26, 2026 --

Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results Globe Newswire 8:30 AM

-- March 25, 2026 --

Quoin Pharmaceuticals Provides Clinical and Regulatory Update from Constructive Type C Meeting with U.S. FDA for QRX003 in Netherton Syndrome Globe Newswire 8:30 AM

-- March 19, 2026 --

Quoin Pharmaceuticals to Announce Corporate Update and Fourth Quarter and Full-Year 2025 Financial Results on Thursday, March 26, 2026 Globe Newswire 8:30 AM

-- March 11, 2026 --

Quoin Pharmaceuticals Announces FDA Grants Fast Track Designation for QRX003 for the Treatment of Netherton Syndrome Globe Newswire 8:30 AM

-- February 26, 2026 --

NETHERTON NOW Recognizes Rare Disease Day and Highlights Growing Global Awareness of Netherton Syndrome Globe Newswire 8:30 AM

-- January 27, 2026 --

Quoin Pharmaceuticals Announces Submission to Japanese MHLW for Orphan Drug Designation for QRX003 in Netherton Syndrome Globe Newswire 8:30 AM

-- January 20, 2026 --

Quoin Pharmaceuticals Files Breakthrough Medicine Designation Application in Saudi Arabia for QRX003 in Netherton Syndrome Globe Newswire 8:30 AM

-- November 11, 2025 --

Quoin Pharmaceuticals Announces Achievement of Topical Rapamycin Target Loadings for Two Proprietary Delivery Technologies Globe Newswire 8:30 AM

-- November 6, 2025 --

Quoin Pharmaceuticals Announces Corporate Update and Third Quarter 2025 Financial Results Globe Newswire 8:30 AM

-- October 30, 2025 --

Quoin Pharmaceuticals to Provide Corporate Update and Announce Third Quarter 2025 Financial Results on Thursday, November 6, 2025 Globe Newswire 8:30 AM
Market Data Delayed 15 Minutes